<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Ocul Biol Dis Infor</journal-id><journal-title-group><journal-title>Journal of Ocular Biology, Diseases, and Informatics</journal-title></journal-title-group><issn pub-type="ppub">1936-8437</issn><issn pub-type="epub">1936-8445</issn><publisher><publisher-name>Humana Press Inc</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">9047</article-id><article-id pub-id-type="doi">10.1007/s12177-009-9047-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Genetic analysis of typical wet-type age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese population</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Goto</surname><given-names>Asako</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Akahori</surname><given-names>Masakazu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Okamoto</surname><given-names>Haru</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Minami</surname><given-names>Masayoshi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Terauchi</surname><given-names>Naoki</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Haruhata</surname><given-names>Yuji</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Obazawa</surname><given-names>Minoru</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Noda</surname><given-names>Toru</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Honda</surname><given-names>Miki</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Mizota</surname><given-names>Atsushi</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Tanaka</surname><given-names>Minoru</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hayashi</surname><given-names>Takaaki</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Tanito</surname><given-names>Masaki</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Ogata</surname><given-names>Naoko</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Iwata</surname><given-names>Takeshi</given-names></name><address><phone>+81-3-34111026</phone><fax>+81-3-34111026</fax><email>iwatatakeshi@kankakuki.go.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Division of Molecular and Cellular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8902 Japan </aff><aff id="Aff2"><label>2</label>Division of Ophthalmology, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro-ku, Tokyo 152-8902 Japan </aff><aff id="Aff3"><label>3</label>Department of Ophthalmology, Juntendo University Urayasu Hospital, 2-1-1, Tomioka, Urayasu, 279-0021 Japan </aff><aff id="Aff4"><label>4</label>Department of Ophthalmology, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo 173-8605 Japan </aff><aff id="Aff5"><label>5</label>Department of Ophthalmology, The Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo 105-8461 Japan </aff><aff id="Aff6"><label>6</label>Department of Ophthalmology, Shimane University Faculty of Medicine, Enya 89-1, Izumo, Shimane 693-8501 Japan </aff><aff id="Aff7"><label>7</label>Department of Ophthalmology, Kansai Medical University, 10-15, Fumizono-cho, Moriguchi, 570-0074 Japan </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>12</month><year>2009</year></pub-date><pub-date pub-type="pmc-release"><day>22</day><month>12</month><year>2009</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2009</year></pub-date><volume>2</volume><issue>4</issue><fpage>164</fpage><lpage>175</lpage><history><date date-type="received"><day>12</day><month>9</month><year>2009</year></date><date date-type="accepted"><day>6</day><month>11</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2009</copyright-statement></permissions><abstract xml:lang="en"><p>Age-related macular degeneration (AMD) is a common cause of blindness in the elderly. Caucasian patients are predominantly affected by the dry form of AMD, whereas Japanese patients have predominantly the wet form of AMD and/or polypoidal choroidal vasculopathy (PCV). Although genetic association in the 10q26 (<italic>ARMS2/HTRA1</italic>) region has been established in many ethnic groups for dry-type AMD, typical wet-type AMD, and PCV, the contribution of the 1q32 (<italic>CFH</italic>) region seem to differ among these groups. Here we show a single nucleotide polymorphism (SNP) in the <italic>ARMS2/HTRA1</italic> locus is associated in the whole genome for Japanese typical wet-type AMD (rs10490924: <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ p = 4.1 \times 10 ^{ - 4}$$\end{document}</tex-math><inline-graphic xlink:href="12177_2009_9047_Article_IEq1.gif"/></alternatives></inline-formula>, OR&#x02009;=&#x02009;4.16) and PCV (rs10490924: <inline-formula id="IEq2"><alternatives><tex-math id="M2">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ p = 3.7 \times 10 ^{ -8}$$\end{document}</tex-math><inline-graphic xlink:href="12177_2009_9047_Article_IEq2.gif"/></alternatives></inline-formula>, OR&#x02009;=&#x02009;2.72) followed by <italic>CFH</italic> (rs800292: <inline-formula id="IEq3"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ p = 7.4 \times 10 ^{ -5}$$\end{document}</tex-math><inline-graphic xlink:href="12177_2009_9047_Article_IEq3.gif"/></alternatives></inline-formula>, OR&#x02009;=&#x02009;2.08; <inline-formula id="IEq4"><alternatives><tex-math id="M4">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ p = 2.6 \times {10^{ - 4}} $$\end{document}</tex-math><inline-graphic xlink:href="12177_2009_9047_Article_IEq4.gif"/></alternatives></inline-formula>, OR&#x02009;=&#x02009;2.00), which differs from previous studies in Caucasian populations. Moreover, a SNP (rs2241394) in complement component <italic>C3</italic> gene showed significant association with PCV (<inline-formula id="IEq5"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ p = 2.5 \times {10^{ - 3}} $$\end{document}</tex-math><inline-graphic xlink:href="12177_2009_9047_Article_IEq5.gif"/></alternatives></inline-formula>, OR&#x02009;=&#x02009;3.47). We conclude that dry-type AMD, typical wet-type AMD, and PCV have both common and distinct genetic risks that become apparent when comparing Japanese versus Caucasian populations.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1007/s12177-009-9047-1) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Age-related macular degeneration</kwd><kwd>Polypoidal choroidal vasculopathy</kwd><kwd>ARMS2</kwd><kwd>HTRA1</kwd><kwd>CFH</kwd><kwd>C3</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Humana Press 2010</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>Age-related macular degeneration (AMD) is the most common cause of blindness in elderly people of European descent and affects more than 1.75 million individuals in the USA alone [<xref ref-type="bibr" rid="CR1">1</xref>]. In Japan, the prevalence of AMD has risen from 0.87% in 1988 to 1.3% in 2003 (Japan Ophthalmologists Association Study Group Report 2006&#x02013;2008). Steady increase of AMD due to longer life span and improvement of diagnostic methods has been observed around the country. The most recent report by Kawasaki et al. describes the prevalence of early stage AMD in the Funagata study (Funagata-cho, Yamagata Prefecture, Japan) as 4.4% while the prevalence of late stage AMD was 1.1%, showing no difference from a Caucasian study in Australia [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p>AMD is considered a multifactorial disease with involvement of genetic, behavior, and environmental factors, and primarily affects the macular region of the retina [<xref ref-type="bibr" rid="CR3">3</xref>]. Clinical phenotypes of AMD are manifold. Small and hard drusen often appear in normal-aged eyes and do not necessarily cause AMD [<xref ref-type="bibr" rid="CR4">4</xref>]. In Caucasians, the early stage of AMD is associated with an increase in the number of large soft drusen and progresses to either the dry form or wet form of the disease [<xref ref-type="bibr" rid="CR3">3</xref>]. In contrast, Japanese patients predominantly exhibit wet-type AMD with choroidal neovascularization and few or no drusen [<xref ref-type="bibr" rid="CR5">5</xref>]. Maruko et al. have classified wet-type AMD patients into three subgroups, namely typical wet-type AMD, polypoidal choroidal vasculopathy (PCV), and retinal angiomatous proliferation (RAP) [<xref ref-type="bibr" rid="CR5">5</xref>]. From 289 Japanese patients examined with wet-type AMD, 35.3%, 54.7%, and 4.5% were diagnosed with typical AMD, PCV, and RAP, respectively. In the remaining 5.5% patients, one eye had PCV and the other eye had typical AMD. Thus, PCV is the predominant subgroup of wet-type AMD in the Japanese population. PCV is characterized by branching of the choroidal vasculature basal to the RPE comprising various sized polypoidal structures connected to the branching vascular network, which can be clearly seen by indocyanine green angiography [<xref ref-type="bibr" rid="CR6">6</xref>]. PCV can be misdiagnosed as typical AMD if only fluorescein angiography is performed. The recent increase in prevalence of PCV is mainly due to the improvement of diagnostic methods. In most Japanese patients, typical wet-type AMD and PCV occur unilaterally (94.1% and 81.6%, respectively) and show a male preponderance (71.6% and 77.8%, respectively) [<xref ref-type="bibr" rid="CR5">5</xref>] consistent with studies of Eastern Asian patients in China and Korea [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. However, in Caucasians, PCV predominantly affects women and occurs bilaterally with a prevalence ranging from 4% to 14%, which is comparably lower than the Eastern Asian populations [<xref ref-type="bibr" rid="CR6">6</xref>]. On the other hand, it has been reported that the incidence of PCV in black individuals exceeds that of Asians [<xref ref-type="bibr" rid="CR6">6</xref>]. Although the phenotypic diversity of AMD has been speculated to be associated with differences in genetic background, this has not been clearly established.</p><p>Initial efforts to investigate the genetic basis of AMD utilized family studies. A concordance for AMD phenotypes in twins, and a higher risk of siblings of individuals with AMD have been reported [<xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>]. These early studies lead to genome-wide linkage analyses using microsatellite markers to search for chromosomal regions associated with affected individuals [<xref ref-type="bibr" rid="CR15">15</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>]. Several candidate regions including 1q32 and 10q26 were confirmed by a meta-analysis [<xref ref-type="bibr" rid="CR25">25</xref>]. Progress in genotyping and sequencing technology extended detailed genetic association studies to the entire genome. Age-related eye disease studies (AREDS) of AMD case-control subjects using 100,000 SNPs resulted in the identification of four chromosomal regions significantly associated with the disease, namely <italic>CFH</italic> (1q32), <italic>ARMS2/HTRA1</italic> (10q26), complement component 2/complement factor B (<italic>C2/BF</italic>, 6p21), and complement component 3 (<italic>C3</italic>, 19p13) [<xref ref-type="bibr" rid="CR26">26</xref>], which is consistent with another genome wide association study recently reported by Swaroop et al. (<italic>IOVS</italic> 2009; 50:ARVO E-Abstract 1614). It should be noted that these genome-wide scans have been conducted on subjects with both the dry and wet form of AMD, with the majority of cases representing the dry form of the disease. However, Zang et al. have identified 34 SNPs which were associated with AMD at <italic>p</italic> value of less than 10<sup>&#x02212;6</sup> in the AREDS Caucasian cohort having typical wet-type AMD [<xref ref-type="bibr" rid="CR27">27</xref>]. They showed that 1q32 and 10q26 were also significantly associated with typical wet-type AMD. To date, there are no genome-wide genetic studies reported for PCV.</p><p>Direct examinations of SNPs in chromosomal regions identified by genome-wide linkage analysis showed that two genomic loci 1q32 and 10q26 including the <italic>CFH</italic>, <italic>ARMS2</italic>, and <italic>HTRA1</italic> genes were associated with AMD in Caucasians and individuals of Hong Kong [<xref ref-type="bibr" rid="CR28">28</xref>&#x02013;<xref ref-type="bibr" rid="CR32">32</xref>]. The association between AMD and three SNPs in these gene regions, namely rs1061170 (<italic>CFH</italic>), rs10490924 (<italic>ARMS2</italic>), and rs11200638 (<italic>HTRA1</italic>), were verified by a number of research groups around the world. We also confirmed the association of rs10490924 and rs11200638 with typical wet-type AMD in the Japanese cohort [<xref ref-type="bibr" rid="CR33">33</xref>]. From our results and others, rs10490924 and rs11200638 have been shown to strongly associate with dry-type AMD [<xref ref-type="bibr" rid="CR34">34</xref>], typical wet-type AMD [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR34">34</xref>], and PCV [<xref ref-type="bibr" rid="CR35">35</xref>]. It is still unclear how these SNPs contribute to the development of different types of AMD. On the other hand, no association was confirmed for rs1061170 in Japanese AMD [<xref ref-type="bibr" rid="CR36">36</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref>]. This is probably due to the lower allele frequency of 0.07&#x02009;&#x000b1;&#x02009;0.02 for this variant in Eastern Asian population compared to the higher frequency of 0.34&#x02009;&#x000b1;&#x02009;0.03 in Caucasians [<xref ref-type="bibr" rid="CR41">41</xref>]. However, rs800292, another coding SNP in the <italic>CFH</italic> gene region originally associated with AMD in Caucasians [<xref ref-type="bibr" rid="CR28">28</xref>], has been shown to associate with typical wet-type AMD and PCV in Japanese and Chinese populations [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR42">42</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref>]. Thus, there is a clear difference in genetic risk for AMD based on ethnicity.</p><p>Since the association between the <italic>CFH</italic> gene and AMD has been established, other components of the complement pathway have been thoroughly examined in Caucasian populations. Among them, the 19p13, 6p21 and 4q25 loci, including the <italic>C2</italic>, <italic>BF</italic>, <italic>C3</italic>, and complement factor I (<italic>CFI</italic>) genes, show strong association with AMD [<xref ref-type="bibr" rid="CR45">45</xref>&#x02013;<xref ref-type="bibr" rid="CR49">49</xref>]. However, it still unclear whether <italic>CFI</italic> or the nearby <italic>PLA2G12A</italic> gene is associated with the disease. Lee et al. analyzed the same AMD associated SNPs in the C2/BF gene region and reported that there were no differences between Chinese PCV patients and control groups [<xref ref-type="bibr" rid="CR43">43</xref>]. Similar results were obtained for PCV in Japanese population for SNPs in the <italic>C2</italic>/<italic>BF</italic> gene region [<xref ref-type="bibr" rid="CR50">50</xref>]. However, in this study, significant association of disease-protective haplotype was observed. There is currently no evidence that the <italic>C2</italic>/<italic>BF</italic> gene region is a risk for wet-type AMD or the <italic>C3</italic> gene region a risk for typical wet-type AMD and PCV for Eastern Asians. With the exception of 1q32, 10q26, 19p13, 6p21, and 4q25 regions, association of other loci with AMD pathogenesis reported by some genome-wide genetic studies remains unclear [<xref ref-type="bibr" rid="CR15">15</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>]. These SNP variants may be ethnic specific as is the case for <italic>CFH</italic>.</p><p>To investigate the involvement of genetic factors in Japanese patients who progressed to typical wet-type AMD and PCV, over 500,568 SNPs covering <italic>ARMS2</italic>/<italic>HTRA1</italic>, <italic>CFH</italic>, <italic>C2</italic>/<italic>BF</italic>, <italic>C3</italic>, and <italic>CFI</italic> and other regions were genotyped using Affymetrix Human Mapping 500&#x000a0;K Arrays and <italic>Taq</italic>Man assay.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Subjects</title><p>One hundred Japanese patients with typical wet-type AMD but without PCV (average age 74.56&#x02009;&#x000b1;&#x02009;8.83&#x000a0;years), classified as 5b by Seddon et al. [<xref ref-type="bibr" rid="CR51">51</xref>], 100 Japanese patients with PCV (average age, 72.71&#x02009;&#x000b1;&#x02009;8.25&#x000a0;years), and 190 age-matched Japanese controls (average age, 72.22&#x02009;&#x000b1;&#x02009;8.51&#x000a0;years) were recruited for this study (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). All patients were diagnosed by ophthalmoscopic, fluorescein, and indocyanine green angiographic findings. In controls, no signs of early AMD, such as soft drusen or alterations of the retinal pigment epithelium in the macula area, were observed ophthalmoscopically. Informed consent was obtained from all participants and the procedures used conformed to the tenets of the Declaration of Helsinki. <table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Summary of study populations</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>AMD</th><th>PCV</th><th>Control</th><th><italic>p</italic> value</th></tr></thead><tbody><tr><td>No. of subjects</td><td>100</td><td>100</td><td>190</td><td/></tr><tr><td>Male/female</td><td>73:27</td><td>81:19</td><td>86:104</td><td>5.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;10</sup></td></tr><tr><td>Mean &#x000b1; SD</td><td>74.56&#x02009;&#x000b1;&#x02009;8.83</td><td>72.71&#x02009;&#x000b1;&#x02009;8.25</td><td>72.22&#x02009;&#x000b1;&#x02009;8.51</td><td>0.08</td></tr><tr><td>Range</td><td>51&#x02013;90</td><td>52&#x02013;89</td><td>50&#x02013;89</td><td/></tr></tbody></table><table-wrap-foot><p><italic>p</italic> values were obtained by Pearson's chi-square test (5.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;10</sup>) and one-way ANOVA (0.08) among three groups</p><p><italic>AMD</italic> typical wet-type AMD</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec4"><title>Genotyping</title><p>DNA was extracted from blood samples using the Magtration System 8Lx (Precision System Science Co., Ltd., Tokyo, Japan), and 50&#x000a0;ng/&#x003bc;l samples were evaluated by gel electrophoresis. Genotyping was performed on the Affymetrix GeneChip&#x000ae; Human Mapping 500&#x000a0;K Array Set (Affymetrix Japan, Tokyo, Japan), according to the manufacturer&#x02019;s instructions. To check the quality of each array, the SNPs were initially genotyped by a DM algorithm using Genotyping Console (Affymetrix). All arrays passed a call rate of 93% at a confidence threshold of 0.33. For the association analysis, we genotyped the SNPs by the Bayesian robust linear model with a Mahalanobis distance classifier (BRLMM) algorithm using Affymetrix Power Tools ver.1.10.0 (Affymetrix). Genotyping using Taqman&#x000ae; SNP Genotyping Assays (Applied Biosystems, Foster City, CA) on a StepOnePlus&#x02122; real-time PCR system (Applied Biosystems) was performed for the following SNPs in accordance with the manufacturer&#x02019;s instructions: rs800292, rs547154, rs2230199, rs10033900 (Assay ID: C_2530382_10, C_940286_10, C_26330755_10, C_34681305_10).</p></sec><sec id="Sec5"><title>Statistical analyses</title><p>Statistical analyses were carried out with the R version of 2.7.0 [<xref ref-type="bibr" rid="CR52">52</xref>]. Deviation of the genotype frequencies in the controls from those expected under Hardy-Weinberg Equilibrium (HWE) was assessed by chi-square test. SNPs with call rate &#x0003c;90% for case and control samples, respectively, a Hardy&#x02013;Weinberg <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0001 for control samples, a minor allele frequency &#x0003c;0.05 for all samples, or those that exhibited poorly defined genotype clusters were disqualified from association analysis. For each case-control study, Fisher&#x02019;s exact test was used to compare allelic or genotypic frequencies in three different models (genotype, dominant, and recessive forms) of each case group with controls. In the allelic model, the allelic frequencies were compared between cases and controls using a 2&#x02009;&#x000d7;&#x02009;2 contingency table. In the genotype model, the frequencies of the three genotypes were compared using a 2&#x02009;&#x000d7;&#x02009;3 contingency table, in the dominant model, the frequencies of the homozygote for the non-risk allele were compared using a 2&#x02009;&#x000d7;&#x02009;2 contingency table, and in the recessive model, the frequencies of the homozygote for the risk allele were compared using a 2&#x02009;&#x000d7;&#x02009;2 contingency table. Also, association analysis was performed with the use of the Cochran&#x02013;Armitage trend test. After statistical analysis in three different models (genotype, recessive, and dominant model) and trend test, the minimum p value of each SNPs were obtained from lowest p value of these tests. The minimum <italic>p</italic> values were used to test whether they were lower than the significance levels. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated for the effects of risk allele and also for both the dominant and recessive forms of the genotypes. To account for multiple statistical testing, the false discovery rate (FDR) was calculated based on the minimum <italic>p</italic> values from each typical type of AMD and PCV case-control study by the method of Benjamini and Hochberg [<xref ref-type="bibr" rid="CR53">53</xref>], and it was employed at a significance level of 0.05. Pair wise SNP linkage disequilibrium (LD) values were calculated from the genotype data using Haploview ver.4.0.</p></sec><sec id="Sec6"><title>Logistic regression analysis and calculation of joint OR</title><p>Logistic regression analysis was performed to assess the joint contributions of the three candidate SNPs (rs800292, rs10490924, and rs2241394) to the risk of typical wet-type AMD or PCV using R software. To model the genetic effects, we adopted the following three genetic models with classification variables: the 2-genotype model (AA+AB and BB or AA and AB+BB) and the 3-genotype model (AA, AB, and BB). The logistic regression models were compared by the Akaike information criterion (AIC) to obtain the best-fitting model with the lowest AIC. Univariate logistic regression analysis was initially carried out for three genotype models on each SNPs, and multivariate analysis was then performed. The logistic regression models for all the possible combinations of SNPs were compared by the AIC to obtain the best-fitting model with the lowest AIC. Joint ORs for pairs of loci (rs10490924 and rs800292; rs10490924 and rs2241394; rs10490924 and rs2241394) were calculated for each 2-locus genotype separately, using the non-risk double homozygote genotype as a reference. The estimation of joint ORs was carried out with the R package Epitools. This analysis added 0.5 to each cell in a case including 0 in contingency table [<xref ref-type="bibr" rid="CR54">54</xref>].</p></sec></sec><sec id="Sec7"><title>Results</title><sec id="Sec8"><title>Genotyping of typical wet-type AMD and PCV</title><p>We conducted genotyping on DNA samples obtained from Japanese patients with typical wet-type AMD and PCV. To increase the power of detecting genetic difference, we selected samples from AMD cases at stage 5b, at least in one eye without PCV, for typical wet-type AMD analysis. Stage 5 is defined as exudative AMD, including nondrusenoid pigment epithelial detachments, serious or hemorrhage retinal detachments, choroidal neovascular membrane with subretinal or sub-RPE hemorrhages or fibrosis, or scars consistent with treatment of AMD. AMD with choroidal neovascular membrane or disciform scar is defined as stage 5b [<xref ref-type="bibr" rid="CR51">51</xref>]. Although the controls were age-matched (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>), the gender of the population was biased because of the characteristically higher incidence of men in Japanese AMD population [<xref ref-type="bibr" rid="CR6">6</xref>]. One hundred cases versus 190 controls were genotyped for 500,568 tag-SNPs using the Affymetrix Human Mapping 500&#x000a0;K Array Set. For typical AMD, statistical analysis was performed for a selected 314,950 tag-SNPs through quality control filters (HWE <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0001, minor allele frequency &#x0003c;5%, and call rate &#x0003c;90%) to reduce low-quality signal. These SNPs are shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref> and <xref rid="Fig1" ref-type="fig">b</xref>, and the 77 SNPs associated with typical wet-type AMD with genotypic <italic>p</italic> values&#x02009;&#x0003c;&#x02009;0.0001 are listed in the Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="">S1</xref>. Our study identified several genomic locations as being potentially associated with AMD risk. Among these SNPs, rs10490924, rs3750848, and rs2672587 with false discovery rate &#x0003c;0.05 (Benjamini&#x02013;Hochberg method) were significantly associated with typical wet-type AMD in Japanese patients with a minimum <italic>p</italic> value of 4.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;14</sup>, 4.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;14</sup> and 2.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;9</sup>, respectively (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). For PCV, statistical analysis was performed for 313,772 quality controlled filtered SNPs. These SNPs are shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c, d</xref>, and the 98 SNPs associated with PCV with genotypic <italic>p</italic> values&#x02009;&#x0003c;&#x02009;0.0001 are listed in Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="">S2</xref>. Two SNPs: rs10490924 and rs3750848 are statistically associated with PCV with a minimum <italic>p</italic> value of 3.7&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup> and 2.4&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup>, respectively. These results confirm a strong association of the <italic>AMRS2</italic>/<italic>HTRA1</italic> gene region with both typical wet-type AMD and PCV in Japanese, however, we could not comprehensively evaluate the association between Japanese AMD and complement related genes probably due to the low statistical power by this method. <fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Genome wide screening for Japanese typical wet-type AMD and PCV. Whole-genome association analyasis of typical wet-type AMD (<bold>a</bold>) and PCV (<bold>c</bold>). The scatter plots were drawn for &#x02212;log10 (minimum <italic>p</italic> value) against SNP position in the chromosomes. Quantile-quantile plot for association results of typical wet-type AMD (<bold>b</bold>) and PCV (<bold>d</bold>). The distribution of observed <italic>p</italic> values versus expected <italic>p</italic> values. <italic>Dots</italic> represent all the 314950 SNPs and 313772 SNPs analyzed for association studies for typical wet-type AMD and PCV, respectively</p></caption><graphic xlink:href="12177_2009_9047_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Statistically significant SNPs associated with typical wet-type AMD and PCV from analysis of candidate gene</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">dbSNP ID (A/B)</th><th rowspan="2">Chr.</th><th rowspan="2">Position</th><th rowspan="2">Associated gene</th><th rowspan="2">SNP type</th><th colspan="3">Case</th><th colspan="3">Control</th><th colspan="3"><italic>p</italic> value</th><th colspan="3">Odds ratio (95% CI)</th></tr><tr><th>AA</th><th>AB</th><th>BB</th><th>AA</th><th>AB</th><th>BB</th><th>Allele</th><th>Minimum</th><th>Model</th><th>Allele</th><th>Recessive</th><th>Dominant</th></tr></thead><tbody><tr><td colspan="17">AMD</td></tr><tr><td>&#x000a0;rs800292 (G/A)</td><td>1</td><td char="." align="char">194,908,856</td><td><italic>CFH</italic></td><td>Exon</td><td char="." align="char">47</td><td char="." align="char">46</td><td char="." align="char">3</td><td char="." align="char">60</td><td char="." align="char">92</td><td char="." align="char">36</td><td>1.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>7.4&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td><td>Genotype</td><td char="(" align="char">2.08 (1.43 &#x02013;3.04)</td><td char="(" align="char">7.34 (2.20 &#x02013;24.52)</td><td char="(" align="char">2.05 (1.24&#x02013;3.39)</td></tr><tr><td>&#x000a0;rs1329423 (G/A)</td><td>1</td><td char="." align="char">194,913,010</td><td><italic>CFH</italic></td><td>Intron</td><td char="." align="char">35</td><td char="." align="char">50</td><td char="." align="char">15</td><td char="." align="char">47</td><td char="." align="char">87</td><td char="." align="char">55</td><td>0.0066</td><td>0.0049</td><td>Trend</td><td char="(" align="char">1.63 (1.15 &#x02013;2.31)</td><td char="(" align="char">2.33 (1.24 &#x02013;4.38)</td><td char="(" align="char">1.63 (0.96&#x02013;2.76)</td></tr><tr><td>&#x000a0;rs10737680 (T/G)</td><td>1</td><td char="." align="char">194,946,078</td><td><italic>CFH</italic></td><td>Intron</td><td char="." align="char">43</td><td char="." align="char">49</td><td char="." align="char">8</td><td char="." align="char">58</td><td char="." align="char">88</td><td char="." align="char">44</td><td>0.0014</td><td>0.0012</td><td>Dominant</td><td char="(" align="char">1.79 (1.25 &#x02013;2.56)</td><td char="(" align="char">3.47 (1.56 &#x02013;7.69)</td><td char="(" align="char">1.72 (1.04&#x02013;2.84)</td></tr><tr><td>&#x000a0;rs742855 (G/A</td><td>1</td><td char="." align="char">194,972,143</td><td><italic>CFH</italic></td><td>Intron</td><td char="." align="char">30</td><td char="." align="char">54</td><td char="." align="char">16</td><td char="." align="char">46</td><td char="." align="char">84</td><td char="." align="char">59</td><td>0.0183</td><td>0.0059</td><td>Dominant</td><td char="(" align="char">1.52 (1.08 &#x02013;2.15)</td><td char="(" align="char">2.38 (1.29 &#x02013;4.42)</td><td char="(" align="char">1.33 (0.78&#x02013;2.29)</td></tr><tr><td>&#x000a0;rs2736911 (G/A)</td><td>10</td><td char="." align="char">124,204,345</td><td><italic>HTRA1</italic></td><td>&#x02212;6,686</td><td char="." align="char">80</td><td char="." align="char">20</td><td char="." align="char">0</td><td char="." align="char">108</td><td char="." align="char">74</td><td char="." align="char">6</td><td>1.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>4.8&#x02009;&#x000d7;&#x02009;110<sup>&#x02212;5</sup></td><td>Trend</td><td char="(" align="char">2.67 (1.59 &#x02013;4.49)</td><td>NA</td><td char="(" align="char">2.96 (1.68 &#x02013;5.23)</td></tr><tr><td>&#x000a0;rs10490924 (A/C)</td><td>10</td><td char="." align="char">124,204,438</td><td><italic>HTRA1</italic></td><td>&#x02212;6,593</td><td char="." align="char">52</td><td char="." align="char">30</td><td char="." align="char">18</td><td char="." align="char">20</td><td char="." align="char">84</td><td char="." align="char">85</td><td>4.5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;15</sup></td><td>4.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;14</sup></td><td>Recessive</td><td char="(" align="char">4.16 (2.89 &#x02013;5.99)</td><td char="(" align="char">3.72 (2.07 &#x02013;6.68)</td><td char="(" align="char">9.15 (4.99 &#x02013;16.80)</td></tr><tr><td>&#x000a0;rs3750848 (C/A)</td><td>10</td><td char="." align="char">124,205,305</td><td><italic>HTRA1</italic></td><td>&#x02212;5,726</td><td char="." align="char">52</td><td char="." align="char">30</td><td char="." align="char">18</td><td char="." align="char">20</td><td char="." align="char">84</td><td char="." align="char">84</td><td>5.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;15</sup></td><td>4.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;14</sup></td><td>Recessive</td><td char="(" align="char">4.13 (2.86 &#x02013;5.94)</td><td char="(" align="char">3.68 (2.05 &#x02013;6.61)</td><td char="(" align="char">9.10 (4.96 &#x02013;16.70)</td></tr><tr><td>&#x000a0;rs11200644 (A/G)</td><td>10</td><td char="." align="char">124,220,931</td><td><italic>HTRA1</italic></td><td>Intron</td><td char="." align="char">76</td><td char="." align="char">23</td><td char="." align="char">0</td><td char="." align="char">105</td><td char="." align="char">79</td><td char="." align="char">6</td><td>3.9&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>1.7&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>Trend</td><td char="(" align="char">2.40 (1.46 &#x02013;3.93)</td><td>NA</td><td char="(" align="char">2.67 (1.55 &#x02013;4.62)</td></tr><tr><td>&#x000a0;rs7093894 (C/A)</td><td>10</td><td char="." align="char">124,224,870</td><td><italic>HTRA1</italic></td><td>Intron</td><td char="." align="char">73</td><td char="." align="char">27</td><td char="." align="char">0</td><td char="." align="char">88</td><td char="." align="char">86</td><td char="." align="char">15</td><td>4.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>3.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>Trend</td><td char="(" align="char">2.84 (1.79 &#x02013;4.50)</td><td>NA</td><td char="(" align="char">3.10 (1.83 &#x02013;5.25)</td></tr><tr><td>&#x000a0;rs2672587 (C/G)</td><td>10</td><td char="." align="char">124,225,345</td><td><italic>HTRA1</italic></td><td>Intron</td><td char="." align="char">47</td><td char="." align="char">38</td><td char="." align="char">15</td><td char="." align="char">29</td><td char="." align="char">85</td><td char="." align="char">74</td><td>2.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;10</sup></td><td>2.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;9</sup></td><td>Trend</td><td char="(" align="char">3.16 (2.21 &#x02013;4.53)</td><td char="(" align="char">3.68 (1.97 &#x02013;6.85)</td><td char="(" align="char">4.86 (2.78 &#x02013;8.49)</td></tr><tr><td>&#x000a0;rs2250804 (G/A)</td><td>10</td><td char="." align="char">124,254,868</td><td><italic>HTRA1</italic></td><td>Intron</td><td char="." align="char">27</td><td char="." align="char">48</td><td char="." align="char">25</td><td char="." align="char">16</td><td char="." align="char">97</td><td char="." align="char">76</td><td>1.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>7.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td><td>Recessive</td><td char="(" align="char">2.01 (1.42 &#x02013;2.85)</td><td char="(" align="char">2.02 (1.18 &#x02013;3.46)</td><td char="(" align="char">4.00 (2.03 &#x02013;7.86)</td></tr><tr><td>&#x000a0;rs2268356 (G/A)</td><td>10</td><td char="." align="char">124,255,316</td><td><italic>HTRA1</italic></td><td>Intron</td><td char="." align="char">47</td><td char="." align="char">40</td><td char="." align="char">12</td><td char="." align="char">59</td><td char="." align="char">104</td><td char="." align="char">24</td><td>0.057</td><td>0.0068</td><td>Recessive</td><td char="(" align="char">1.43 (1.00 &#x02013;2.06)</td><td char="(" align="char">1.07 (0.51 &#x02013;2.24)</td><td char="(" align="char">1.96 (1.19 &#x02013;3.24)</td></tr><tr><td colspan="17">PCV</td></tr><tr><td>&#x000a0;rs800292 (G/A)</td><td>1</td><td char="." align="char">194,908,856</td><td><italic>CFH</italic></td><td>Exon</td><td char="." align="char">5</td><td char="." align="char">43</td><td char="." align="char">47</td><td char="." align="char">36</td><td char="." align="char">92</td><td char="." align="char">60</td><td>3.4&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>2.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>Trend</td><td char="(" align="char">2.00 (1.37 &#x02013;2.92)</td><td char="(" align="char">4.26 (1.61 &#x02013;11.26)</td><td char="(" align="char">2.09 (1.26 &#x02013;3.46)</td></tr><tr><td>&#x000a0;rs10490924 (A/C)</td><td>10</td><td char="." align="char">124,204,438</td><td><italic>HTRA1</italic></td><td>&#x02212;6,593</td><td char="." align="char">32</td><td char="." align="char">50</td><td char="." align="char">18</td><td char="." align="char">20</td><td char="." align="char">84</td><td char="." align="char">85</td><td>3.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup></td><td>3.7&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup></td><td>Trend</td><td char="(" align="char">2.72 (1.91 &#x02013;3.86)</td><td char="(" align="char">3.72 (2.07 &#x02013;6.68)</td><td char="(" align="char">3.98 (2.13 &#x02013;7.43)</td></tr><tr><td>&#x000a0;rs3750848 (C/A)</td><td>10</td><td char="." align="char">124,205,305</td><td><italic>HTRA1</italic></td><td>&#x02212;5,726</td><td char="." align="char">17</td><td char="." align="char">50</td><td char="." align="char">32</td><td char="." align="char">84</td><td char="." align="char">84</td><td char="." align="char">20</td><td>1.7&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup></td><td>2.4&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup></td><td>Trend</td><td char="(" align="char">2.76 (1.93 &#x02013;3.93)</td><td char="(" align="char">3.90 (2.15 &#x02013;7.07)</td><td char="(" align="char">4.01 (2.14 &#x02013;7.51)</td></tr><tr><td>&#x000a0;rs11200644 (A/G)</td><td>10</td><td char="." align="char">124,220,931</td><td><italic>HTRA1</italic></td><td>Intron</td><td char="." align="char">72</td><td char="." align="char">26</td><td char="." align="char">2</td><td char="." align="char">105</td><td char="." align="char">79</td><td char="." align="char">6</td><td>0.0132</td><td>0.0055</td><td>Recessive</td><td char="(" align="char">1.78 (1.13 &#x02013;2.81)</td><td char="(" align="char">1.60 (0.32 &#x02013;8.07)</td><td char="(" align="char">2.08 (1.24 &#x02013;3.51)</td></tr><tr><td>&#x000a0;rs7093894 (C/A)</td><td>10</td><td char="." align="char">124,224,870</td><td><italic>HTRA1</italic></td><td>Intron</td><td char="." align="char">4</td><td char="." align="char">29</td><td char="." align="char">67</td><td char="." align="char">15</td><td char="." align="char">86</td><td char="." align="char">88</td><td>0.0015</td><td>0.0012</td><td>Recessive</td><td char="(" align="char">1.95 (1.28)</td><td char="(" align="char">2.07 (0.67 &#x02013;6.41)</td><td char="(" align="char">2.33 (1.41 &#x02013;3.86)</td></tr><tr><td>&#x000a0;rs2672587 (C/G)</td><td>10</td><td char="." align="char">124,225,345</td><td><italic>HTRA1</italic></td><td>Intron</td><td char="." align="char">26</td><td char="." align="char">55</td><td char="." align="char">18</td><td char="." align="char">29</td><td char="." align="char">85</td><td char="." align="char">74</td><td>2.8&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>2.5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>Trend</td><td char="(" align="char">1.92 (1.35 &#x02013;2.71)</td><td char="(" align="char">2.92 (1.62 &#x02013;5.26)</td><td char="(" align="char">1.95 (1.07 &#x02013;9.55)</td></tr><tr><td>&#x000a0;rs2241394 (G/C)</td><td>19</td><td char="." align="char">6,636,260</td><td><italic>C</italic>3</td><td>Intron</td><td char="." align="char">0</td><td char="." align="char">6</td><td char="." align="char">93</td><td char="." align="char">2</td><td char="." align="char">33</td><td char="." align="char">154</td><td>0.0025</td><td>0.0037</td><td>Trend</td><td char="(" align="char">3.47 (1.48 &#x02013;8.38)</td><td>NA</td><td char="(" align="char">3.52 (1.43 &#x02013;8.69)</td></tr></tbody></table><table-wrap-foot><p>Allele <italic>p</italic> values were obtained from Fisher&#x02019;s exact test. Minimum <italic>p</italic> values were obtained from lowest <italic>p</italic> value of Fisher&#x02019;s exact test for three disease-risk models (genotype, dominant, and recessive model) and Cochran-Armitage trend test. Model showed the genetic model which minimum <italic>p</italic> value was found in. <italic>AMD</italic> typical wet-type AMD, <italic>Chr.</italic> chromosome number, <italic>A</italic> risk allele, <italic>B</italic> non-risk allele, <italic>CI</italic> confidence interval</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec9"><title>Analysis of the SNPs in <italic>ARMS2/HTRA1</italic>, <italic>CFH</italic>, <italic>C2/BF</italic>, <italic>C3</italic>, and <italic>CFI</italic> gene regions</title><p>Despite the success of many genome wide association study published, not all the genome wide screening data are analyzed to their full potential. Thus, recently the advantage of association analysis on candidate genes selected by certain criteria has been proposed. We extracted genotyping data in gene regions, which were associated with typical wet-type AMD in Caucasian populations, namely <italic>ARMS2</italic>/<italic>HTRA1</italic>, <italic>CFH</italic>, <italic>C2</italic>/<italic>BF</italic>, <italic>C3</italic>, and <italic>CFI</italic>. Using <italic>Taq</italic>Man analysis, we additionally genotyped four SNPs; rs800292 (<italic>CFH</italic>), rs547154 (<italic>C2</italic>), rs2230199 (<italic>C3</italic>), and rs10033900 (<italic>CFI</italic>), which were significantly associated with Caucasian typical wet-type AMD but were not covered in the Affymetrix Human Mapping 500&#x000a0;K Array. rs800292 shows association with both typical wet-type AMD and PCV (10<sup>&#x02212;4</sup>&#x02009;&#x0003c;&#x02009;<italic>p</italic>&#x02009;&#x0003c;&#x02009;10<sup>&#x02212;3</sup>, Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>) as reported previously [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. No difference in genetic frequency between case and control was detected for rs547154, rs10033900, and rs2230199. After Benjamini&#x02013;Hochberg correction, 12 and seven SNPs showing significant association with typical wet-type AMD and PCV, respectively (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>), were found at the threshold FDR &#x0003c;0.05. For typical wet-type AMD, four SNPs in the <italic>CFH</italic> gene region including rs800292 appeared to be significantly associated following the <italic>ARMS2</italic>/<italic>HTRA1</italic> gene region. While in PCV, rs800292 in the <italic>CFH</italic> gene region and rs2241394 in the <italic>C3</italic> gene region were significantly associated with the <italic>ARMS2</italic>/<italic>HTRA1</italic> gene region. These results indicate common and distinctive aspects of genetic background between typical wet-type AMD and PCV in Japanese population. We also used logistic regression to further compare the genetic risk properties of typical wet-type AMD and PCV. Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> summarizes the best-fit and most parsimonious model analyzed by logistic regression, which was used to explore the joint contributions of the three candidate SNPs (rs800292, rs10490924, and rs2241394) to the risk of typical wet-type AMD and PCV. The AIC for three genetic models of the candidate SNPs were compared, followed by logistic regression analysis to assess the joint contributions of the genetic models with the lowest AIC. These results suggest that the joint effect of rs800292, rs10490924, and rs2241394 best described the risk for development of PCV. However, an effect of rs2241394 was not observed for typical wet-type AMD. Independent and joint ORs of typical wet-type AMD combining the genotypes from the rs800292 and rs10490924 or PCV for the two variants among rs800292, rs10490924 and rs2241394 were estimated (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). When three SNPs were combined, some values appeared to be unreliable because of small numbers of individuals in some of the genotype combinations. Therefore, two SNPs were analyzed. The heterozygous (CA) risk genotype of rs10490924 was detected more often in PCV cases than in controls with <italic>p</italic> value of 0.0008 and OR of 2.8 (95% CI&#x02009;=&#x02009;1.5&#x02013;5.2), however the difference in the frequency of the heterozygous (CA) at the same loci between typical wet-type AMD cases and controls did not reach statistical significance. Both typical wet-type AMD and PCV cases carried the rs800292 heterozygous (AG) and homozygous (GG) risk genotype more often than the non-risk genotype (AA) (typical wet-type AMD cases: <italic>p</italic>&#x02009;=&#x02009;0.001, OR&#x02009;=&#x02009;6.0; AG and <italic>p</italic>&#x02009;=&#x02009;2.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>, OR&#x02009;=&#x02009;9.4; GG, PCV cases: <italic>p</italic>&#x02009;=&#x02009;0.016, OR&#x02009;=&#x02009;3.4; AG and <italic>p</italic>&#x02009;=&#x02009;0.0002, OR&#x02009;=&#x02009;5.6; GG). A joint OR of 53.5 for typical wet-type AMD in individuals with homozygous (AA and GG) risk alleles at both loci was observed when compared with the non-risk genotype (CC and AA), with a wide range of calculated 95% CI from 7.9 to 361.0. Similarly, a joint OR of 87.4 for PCV in individuals with homozygous (AA and GG) risk alleles at the same loci was observed. A joint analysis of ORs for the rs10490924 and rs2241394 showed that the risk of PCV was 5.4-fold (<italic>&#x02009;p</italic>&#x02009;=&#x02009;0.017) and 12.8-fold (<italic>&#x02009;p</italic>&#x02009;=&#x02009;0.0004) if individuals had homozygous (GG) risk genotype of rs2241394 and heterozygous (CA) and homozygous (AA) risk genotype of rs10490924, respectively, compared with the non-risk genotype. A plot of the two-locus genotype specific for typical wet-type AMD and PCV risks further illustrates the stronger impact of rs10490924 on these diseases (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). <fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Schematic view of association and LD results from association analysis for typical wet-type AMD and PCV in the significantly associated region. <italic>Upper panel</italic>, SNPs association results in the chromosome 1 (<bold>a</bold>), chromosome 10 (<bold>b</bold>), and chromosome 19 (<bold>c</bold>). This panel shows <italic>p</italic> values for association testing drawn from the candidate genes focused study including results using <italic>Taq</italic>man genotyping assay. Known genes in the area are shown. <italic>Down panel</italic>, LD structure of each region. Pairwise LD was calculated from all the data set in this study using the methods of Gabriel as implemented in Haploview. In each <italic>box</italic> are shown are the LD relationships between each SNP pair using Haploview's standard color scheme. <italic>Blue circles</italic>, typical wet-type AMD; <italic>Red circles</italic>, PCV</p></caption><graphic xlink:href="12177_2009_9047_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Calculation of AIC by logistic regression analysis in three genotype models</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">dbSNP ID</th><th rowspan="2">Model</th><th colspan="2">AMD</th><th colspan="2">PCV</th></tr><tr><th>AIC</th><th>AIC difference</th><th>AIC</th><th>AIC difference</th></tr></thead><tbody><tr><td colspan="6">Single</td></tr><tr><td rowspan="3">&#x000a0;rs800292</td><td>Gen</td><td char="." align="char">349.6</td><td/><td char="." align="char">352.1</td><td/></tr><tr><td>Rec</td><td char="." align="char">350.4</td><td/><td char="." align="char">353.8</td><td/></tr><tr><td>Dom</td><td char="." align="char">359.6</td><td/><td char="." align="char">357</td><td/></tr><tr><td rowspan="3">&#x000a0;rs10490924</td><td>Gen</td><td char="." align="char">317.9</td><td/><td char="." align="char">347.8</td><td/></tr><tr><td>Rec</td><td char="." align="char">354.7</td><td/><td char="." align="char">354.7</td><td/></tr><tr><td>Dom</td><td char="." align="char">318.4</td><td/><td char="." align="char">357.4</td><td/></tr><tr><td rowspan="3">&#x000a0;rs2241394</td><td>Gen</td><td char="." align="char">375.4</td><td/><td char="." align="char">366.7</td><td/></tr><tr><td>Rec</td><td char="." align="char">345.1</td><td/><td char="." align="char">373</td><td/></tr><tr><td>Dom</td><td char="." align="char">374.7</td><td/><td char="." align="char">365.3</td><td/></tr><tr><td colspan="6">Joint</td></tr><tr><td>&#x000a0;rs800292gen + rs10490924gen</td><td/><td char="." align="char">291.8</td><td char="." align="char">0</td><td char="." align="char">325.9</td><td char="." align="char">5.5</td></tr><tr><td>&#x000a0;rs800292gen + rs2241394dom</td><td/><td char="." align="char">349.2</td><td char="." align="char">57.4</td><td char="." align="char">344</td><td char="." align="char">23.6</td></tr><tr><td>&#x000a0;rs10490924gen + rs2241394dom</td><td/><td char="." align="char">319.2</td><td char="." align="char">27.4</td><td char="." align="char">344</td><td char="." align="char">23.6</td></tr><tr><td>&#x000a0;rs800292gen + rs10490924gen + rs2241394dom</td><td/><td char="." align="char">293.4</td><td char="." align="char">1.6</td><td char="." align="char">320.4</td><td char="." align="char">0</td></tr></tbody></table><table-wrap-foot><p><italic>AMD</italic> typical wet-type AMD, <italic>Gen</italic> genotype model, <italic>Rec</italic> recessive model, <italic>Dom</italic> dominant model, <italic>AIC</italic> Akaike information criterion (the AIC difference is the difference from the AIC of the best fitting model)</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Two-locus odds ratios and <italic>p</italic> values for different genotypic combinations of the rs800292, rs10490924, and rs2241394 polymorphisms</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="5">Genotype combination</th><th colspan="4">Number (%)</th></tr><tr><th>Control</th><th>Case</th><th>Odds ratio (95%CI)</th><th><italic>p</italic> value</th></tr></thead><tbody><tr><td rowspan="17">AMD</td><td colspan="8">Single</td></tr><tr><td rowspan="3">rs800292</td><td>AA</td><td/><td/><td char="(" align="char">36 (0.19)</td><td char="(" align="char">3 (0.03)</td><td>1</td><td/></tr><tr><td>AG</td><td/><td/><td char="(" align="char">92 (0.49)</td><td char="(" align="char">46 (0.48)</td><td>6.00 (1.75&#x02013;20.52)</td><td>0.0011</td></tr><tr><td>GG</td><td/><td/><td char="(" align="char">60 (0.32)</td><td char="(" align="char">47 (0.49)</td><td>9.40 (2.73&#x02013;32.42)</td><td>2.3&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td></tr><tr><td rowspan="3">rs10490924</td><td>CC</td><td/><td/><td char="(" align="char">85 (0.45)</td><td char="(" align="char">18 (0.18)</td><td>1</td><td/></tr><tr><td>CA</td><td/><td/><td char="(" align="char">84 (0.44)</td><td char="(" align="char">30 (0.3)</td><td>1.69 (0.87&#x02013;3.26)</td><td>0.1411</td></tr><tr><td>AA</td><td/><td/><td char="(" align="char">20 (0.11)</td><td char="(" align="char">52 (0.52)</td><td>12.28 (5.95&#x02013;25.33)</td><td>2.9&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;13</sup></td></tr><tr><td colspan="8">Joint</td></tr><tr><td rowspan="9">rs10490924</td><td rowspan="3">CC</td><td>rs800292</td><td>AA</td><td char="(" align="char">15 (0.05)</td><td char="(" align="char">1 (0)</td><td>1</td><td/></tr><tr><td/><td>AG</td><td char="(" align="char">38 (0.13)</td><td char="(" align="char">11 (0.04)</td><td>3.09 (0.51&#x02013;18.69)</td><td>0.3234</td></tr><tr><td/><td>GG</td><td char="(" align="char">32 (0.11)</td><td char="(" align="char">5 (0.02)</td><td>1.75 (0.26&#x02013;11.74)</td><td>1</td></tr><tr><td rowspan="3">CA</td><td/><td>AA</td><td char="(" align="char">15 (0.05)</td><td char="(" align="char">0 (0)</td><td>0.33 (0.01&#x02013;8.83)</td><td>0.4866</td></tr><tr><td/><td>AG</td><td char="(" align="char">45 (0.16)</td><td char="(" align="char">15 (0.05)</td><td>3.52 (0.6&#x02013;20.71)</td><td>0.3353</td></tr><tr><td/><td>GG</td><td char="(" align="char">23 (0.08)</td><td char="(" align="char">14 (0.05)</td><td>6.38 (1.05&#x02013;38.54)</td><td>0.061</td></tr><tr><td rowspan="3">AA</td><td/><td>AA</td><td char="(" align="char">6 (0.02)</td><td char="(" align="char">2 (0.01)</td><td>3.97 (0.43&#x02013;36.66)</td><td>0.5633</td></tr><tr><td/><td>AG</td><td char="(" align="char">8 (0.03)</td><td char="(" align="char">20 (0.07)</td><td>24.92 (3.89&#x02013;159.6)</td><td>7.1&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td></tr><tr><td/><td>GG</td><td char="(" align="char">5 (0.02)</td><td char="(" align="char">28 (0.1)</td><td>53.55 (7.94&#x02013;361.02)</td><td/></tr><tr><td rowspan="25">PCV</td><td colspan="8">Single</td></tr><tr><td rowspan="3">rs800292</td><td>GG</td><td/><td/><td char="(" align="char">36 (0.19)</td><td char="(" align="char">5 (0.05)</td><td>1</td><td/></tr><tr><td>GA</td><td/><td/><td char="(" align="char">92 (0.49)</td><td char="(" align="char">43 (0.45)</td><td>3.37 (1.23&#x02013;9.18)</td><td>0.0156</td></tr><tr><td>AA</td><td/><td/><td char="(" align="char">60 (0.32)</td><td char="(" align="char">47 (0.49)</td><td>5.64 (2.05&#x02013;15.49)</td><td/></tr><tr><td rowspan="3">rs10490924</td><td>CC</td><td/><td/><td char="(" align="char">85 (0.45)</td><td char="(" align="char">18 (0.18)</td><td>1</td><td/></tr><tr><td>CA</td><td/><td/><td char="(" align="char">84 (0.44)</td><td char="(" align="char">50 (0.5)</td><td>2.81 (1.52&#x02013;5.21)</td><td>0.0008</td></tr><tr><td>AA</td><td/><td/><td char="(" align="char">20 (0.11)</td><td char="(" align="char">32 (0.32)</td><td>7.56 (3.55&#x02013;16.08)</td><td>6.0&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup></td></tr><tr><td rowspan="2">rs2241394</td><td>CC + CG</td><td/><td/><td char="(" align="char">35 (0.19)</td><td char="(" align="char">6 (0.06)</td><td>1</td><td/></tr><tr><td>GG</td><td/><td/><td char="(" align="char">154 (0.81)</td><td char="(" align="char">93 (0.94)</td><td>3.52 (1.43&#x02013;8.69)</td><td>0.0041</td></tr><tr><td colspan="8">Joint</td></tr><tr><td rowspan="9">rs10490924</td><td rowspan="3">CC</td><td>rs80092</td><td>AA</td><td char="(" align="char">15 (0.05)</td><td char="(" align="char">0 (0)</td><td>1</td><td/></tr><tr><td/><td>AG</td><td char="(" align="char">38 (0.13)</td><td char="(" align="char">7 (0.02)</td><td>6.04 (0.32&#x02013;112.28)</td><td>0.0994</td></tr><tr><td/><td>GG</td><td char="(" align="char">32 (0.11)</td><td char="(" align="char">11 (0.04)</td><td>10.97 (0.61&#x02013;198.43)</td><td>0.0253</td></tr><tr><td rowspan="3">CA</td><td/><td>AA</td><td char="(" align="char">15 (0.05)</td><td char="(" align="char">4 (0.01)</td><td>9.00 (0.45&#x02013;181.74)</td><td>0.1131</td></tr><tr><td/><td>AG</td><td char="(" align="char">45 (0.16)</td><td char="(" align="char">24 (0.09)</td><td>16.69 (0.96&#x02013;291.08)</td><td>0.0043</td></tr><tr><td/><td>GG</td><td char="(" align="char">23 (0.08)</td><td char="(" align="char">21 (0.07)</td><td>28.36 (1.6&#x02013;503.36)</td><td>0.0005</td></tr><tr><td rowspan="3">AA</td><td/><td>AA</td><td char="(" align="char">6 (0.02)</td><td char="(" align="char">1 (0)</td><td>7.15 (0.26&#x02013;199.68)</td><td>0.1014</td></tr><tr><td/><td>AG</td><td char="(" align="char">8 (0.03)</td><td char="(" align="char">12 (0.04)</td><td>45.59 (2.39&#x02013;869.16)</td><td>0.0002</td></tr><tr><td/><td>GG</td><td char="(" align="char">5 (0.05)</td><td char="(" align="char">15 (0.05)</td><td>87.36 (4.44&#x02013;1,719.03)</td><td>4.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td></tr><tr><td rowspan="6">rs10490924</td><td rowspan="2">CC</td><td>rs2241394</td><td>CC+CG</td><td char="(" align="char">15 (0.08)</td><td char="(" align="char">2 (0.02)</td><td>1</td><td/></tr><tr><td/><td>GG</td><td char="(" align="char">70 (0.37)</td><td char="(" align="char">16 (0.16)</td><td>1.71 (0.36&#x02013;8.26)</td><td>0.7302</td></tr><tr><td rowspan="2">CA</td><td/><td>CC+CG</td><td char="(" align="char">17 (0.09)</td><td char="(" align="char">2 (0.02)</td><td>0.88 (0.11&#x02013;7.06)</td><td>1</td></tr><tr><td/><td>GG</td><td char="(" align="char">67 (0.35)</td><td char="(" align="char">48 (0.48)</td><td>5.37 (1.17&#x02013;24.6)</td><td>0.0172</td></tr><tr><td rowspan="2">AA</td><td/><td>CC+CG</td><td char="(" align="char">3 (0.02)</td><td char="(" align="char">2 (0.02)</td><td>5.00 (0.49&#x02013;50.83)</td><td>0.2098</td></tr><tr><td/><td>GG</td><td char="(" align="char">17 (0.09)</td><td char="(" align="char">29. (0.29)</td><td>12.79 (2.6&#x02013;62.88)</td><td>0.0004</td></tr></tbody></table><table-wrap-foot><p>AMD, typical wet-type AMD; 95%CI, 95% confidence intervals; p values were obtained from Fisher&#x02019;s exact text</p></table-wrap-foot></table-wrap><fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Schematic view of two-locus odds ratios. <italic>Upper panel</italic>, independently genetic effect of rs10490924 (<bold>a</bold>) and rs800292 (<bold>b</bold>). <italic>Blue boxes</italic>, typical wet-type AMD; <italic>Purple boxes</italic>, PCV. <italic>Down panel</italic>, joint effect of indicated SNPs to typical wet-type AMD and PCV. Joint odds ratios for the combination of rs10490924 and rs800292 for typical wet-type AMD (<bold>c</bold>), rs10490924 and rs800292 for PCV (<bold>d</bold>), and rs10490924 and rs2241394 (<bold>e</bold>) are shown. The combinations had statistically significant odds ratio are <italic>colored</italic>. <italic>AMD</italic> typical wet-type AMD</p></caption><graphic xlink:href="12177_2009_9047_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec10"><title>LD block analyses</title><p>rs800292 and rs1061170 are located within exon 2 and exon 9, respectively, of the <italic>CFH</italic> gene on chromosome 1. rs800292 was included in LD block 1 indicated in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref>. rs1061170 was located in a different LD block from rs800292 (data not shown). The leading two SNPs rs10490924 and rs3750848, which have been reported to associate with AMD [<xref ref-type="bibr" rid="CR30">30</xref>], maps to a small LD block 1 on chromosome 10 (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>). rs10490924 and rs3750848 were located within exon 1 and intron 1 of <italic>ARMS2</italic>. Another SNP, rs2672587, included in the intronic region of <italic>HTRA1</italic> is located downstream of the leading two SNPs between block 1 and 2 (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>). rs2230199 and rs2241394 were located within exon3 and intron 13 of the <italic>C</italic>3 gene, respectively on chromosome 19. rs2241394 was not included in LD blocks indicated in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c</xref>.</p></sec></sec><sec id="Sec11"><title>Discussion</title><p>We performed a first genome wide genotyping of Japanese patients with typical wet-type AMD and PCV using Affymetrix GeneChip&#x000ae; Human Mapping 500&#x000a0;K Array and <italic>Taq</italic>Man assay. Previous genome wide scans on individuals with the dry and wet-type AMD in Caucasian populations indicated that <italic>CFH</italic> and <italic>ARMS2/HTRA1</italic> are the two most significantly associated gene regions for AMD followed by <italic>C2/BF</italic>, <italic>C3</italic>, and <italic>CFI</italic> [<xref ref-type="bibr" rid="CR15">15</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR26">26</xref>] (Swaroop A, et al. <italic>IOVS</italic> 2009; 50: ARVO E-Abstract 1614). Interestingly, Swaroop et al., reported that the most significantly associated gene locus was <italic>CFH</italic> at <italic>p</italic> values &#x02009;&#x0003c;&#x02009;10<sup>&#x02212;74</sup> followed by <italic>ARMS2</italic> at <italic>p</italic> values&#x02009; &#x0003c;&#x02009;10<sup>&#x02212;57</sup>. In contrast, the Japanese typical wet-type AMD patients showed stronger association with <italic>AMRS2/HTRA1</italic> compared to <italic>CFH</italic> (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Affymetrix GeneChip&#x000ae; Human Mapping 500&#x000a0;K Array used in this study contained 19 SNPs covering the <italic>CFH</italic> gene region (13 SNPs passed the quality control filters). The LD blocks in this region are notably large and with the additional genotyping of rs800292 by <italic>Taq</italic>Man assay, the whole <italic>CFH</italic> gene region has been covered. Thus, the association of rs800292 with typical wet-type AMD and PCV has been confirmed, and the results in this study clearly indicate a lower contribution of <italic>CFH</italic> compared to <italic>AMRS2/HTRA1</italic> on typical wet-type AMD and PCV in the Japanese AMD population. This is consistent with our earlier findings together with others, which have shown lower association of <italic>CFH</italic> compared to <italic>ARMS2/HTRA1</italic> for AMD in Japanese individuals [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR38">38</xref>&#x02013;<xref ref-type="bibr" rid="CR41">41</xref>]. Furthermore, recent studies demonstrated that 10q26 is more strongly associated than 1q32 in wet-type AMD in Caucasian populations [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Combining the results of our study with previous studies suggests that <italic>CFH</italic> and <italic>ARMS2/HTRA1</italic> independently influence the progression of both dry-type and wet-type AMD. Taking into consideration, the lower association of rs1061170 and other variations in <italic>CFH</italic> gene reported in Chinese [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>] and Korean populations [<xref ref-type="bibr" rid="CR57">57</xref>], our results may have revealed some of the common features of AMD patients among East Asian. However, it should be noted that despite the low frequency of the risk allele, a significant association between the rs1061170 variant and typical wet-type AMD have been demonstrated in some Chinese population [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. As Chu et al. have suggested in their paper, the existence of ethnic group variation within the East Asian population is possible [<xref ref-type="bibr" rid="CR59">59</xref>]. We also performed additional genotyping of SNPs in the <italic>C2</italic>/<italic>BF</italic>, <italic>C3</italic>, and <italic>CFI</italic> gene regions, with SNPs not included on the SNP array. rs547154 (<italic>C2</italic>) is one of the protective haplotype-tagging SNPs originally reported by Gold et al. [<xref ref-type="bibr" rid="CR45">45</xref>] who discovered a risk haplotype and two protective haplotypes. Kondo et al. have examined the effects of 11 SNPs in the above gene region in Japanese PCV cases [<xref ref-type="bibr" rid="CR50">50</xref>]. Although individual SNPs were not associated, statistically significant association of a protective haplotype was found. This protective haplotype was different from the two haplotypes described by Gold et al. It is unclear whether this difference is due to the difference in pathogenesis between dry-type AMD and PCV or ethnicity. As for rs2230199 (<italic>C3</italic>), the risk allele frequency was 0 in subjects analyzed in this study, which was consistent with the data from the Hap Map project. The risk allele for rs2230199 was 0.175 in European population (Hap Map project). In our study, rs2241394 in intron 13 of <italic>C3</italic> gene showed significant association with PCV but not with typical wet-type AMD (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).</p><p>The risk of typical wet-type AMD associated with rs10490924 was very high (OR&#x02009;=&#x02009;12.3; 95% CI&#x02009;=&#x02009;6.0&#x02013;25.3), whereas the risk of PCV conferred by rs10490924 (OR&#x02009;=&#x02009;7.6; 95% CI&#x02009;=&#x02009;3.5&#x02013;16.1) was similar to the risk of rs800292 (OR&#x02009;=&#x02009;5.6; 95% CI&#x02009;=&#x02009;2.1&#x02013;15.5) (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Tam et al. reported that combined rs11200638 and rs800292 caused a 23.3-fold increased risk for exudative AMD [<xref ref-type="bibr" rid="CR60">60</xref>]. rs11200638 is a SNP shown to be in LD with rs10490924 [<xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>]. Similarly, our results showed that the joint risk of rs10490924 and rs800292 for PCV was 87.4-fold (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).</p><p>Structures of CFH and C3 have been reported previously [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. CFH consists of twenty short consensus repeats, each presumed to fold into a distinct structure termed the complement control protein module (CCP) [<xref ref-type="bibr" rid="CR61">61</xref>]. Y402H (rs1061170) and I62V (rs800292) are located in the CCP1 and CCP7, which are implicated in C3/C3b binding and polyanion binding, respectively [<xref ref-type="bibr" rid="CR61">61</xref>]. Accordingly, rs1061170 and rs800292 polymorphisms may differentially influence the CFH activity. C3 consist of multiple domains [<xref ref-type="bibr" rid="CR62">62</xref>]. R80G (rs2230199) is included in the macroglobulin (MG) 1 domain which is located in the electropositive patch essential for binding target surfaces such as bacterial cells or apoptotic host cells [<xref ref-type="bibr" rid="CR62">62</xref>]. rs2241394, which is located in intron 13 of the <italic>C3</italic> gene, showed strong associated with PCV in this study (Fig. <xref rid="Fig2" ref-type="fig">2c</xref>). Interestingly, exons 13 and 14 adjacent to rs2241394 encode the MG5 domain, which is also located within the electropositive patch together with MG1 domain. To investigate the molecular mechanism of PCV pathogenesis related to rs2241394, further exploration of SNPs within this region is needed.</p><p>The LD block including <italic>ARMS2</italic> contains two of the significantly associated SNPs, rs10490924 and rs3750848 (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>, Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Another significantly associated SNP, rs2672587, was in the intronic region of <italic>HTRA1</italic>, located approximately 6&#x000a0;Kbp downstream of <italic>ARMS2</italic> (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>, Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>). The rs11200638 located 512&#x000a0;bp upstream of the transcription initiation point is absent in the Affymetrix Human Mapping 500&#x000a0;K Array but has been reported to associate with AMD at a level comparable to rs10490924 [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Our genotyping of rs11200638 by sequencing also confirmed this result [<xref ref-type="bibr" rid="CR33">33</xref>]. Our data indicate that both rs11200638 and rs10490924 share the same LD block which contains <italic>ARMS2</italic> and <italic>HTRA1</italic> but different from rs2672587 (data not shown). This result is consistent with previous Caucasian studies [<xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>]. Some of the candidate loci appeared in this study may be specific to the Japanese AMD population or critical for the development of AMD in combination with <italic>ARMS2</italic> (rs10490924) and/or <italic>HTRA1</italic> (rs11200638), and other behavioral, nutritional, and environmental factors. Further replication and detailed experiments are needed.</p></sec><sec sec-type="supplementary-material"><sec id="AppESM1"><title>Electronic supplementary material</title><supplementary-material id="d28e3705" content-type="local-data"><p>Below is the link to the electronic supplementary material. </p><media xlink:href="12177_2009_9047_Tab1_ESM.tif" id="MOESM1" mimetype="image" mime-subtype="tiff"><label>Supplementary Table S1</label><caption><p>High resolution (TIFF 28.3&#x000a0;MB)</p></caption></media><media xlink:href="12177_2009_9047_Tab2_ESM.tif" id="MOESM2" mimetype="image" mime-subtype="tiff"><label>Supplementary Table S2</label><caption><p>High resolution (TIFF 21.7&#x000a0;MB)</p></caption></media><media xlink:href="12177_2009_9047_Tab3_ESM.tif" id="MOESM3" mimetype="image" mime-subtype="tiff"><label>Supplementary Table S3</label><caption><p>High resolution (TIFF 28.3&#x000a0;MB)</p></caption></media><media xlink:href="12177_2009_9047_Tab4_ESM.tif" id="MOESM4" mimetype="image" mime-subtype="tiff"><label>Supplementary Table S4</label><caption><p>High resolution (TIFF 23.2&#x000a0;MB)</p></caption></media><media xlink:href="12177_2009_9047_Tab5_ESM.tif" id="MOESM5" mimetype="image" mime-subtype="tiff"><label>Supplementary Table S5</label><caption><p>High resolution (TIFF 12.0&#x000a0;MB)</p></caption></media></supplementary-material></sec></sec></body><back><ack><p>We are grateful to all patients and their families who participated in this study. This study was supported in part by the grant to TI from the National Hospital Organization and the Japanese Ministry of Health, Welfare, and Labour of Japan.</p><p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>CC</given-names></name></person-group><article-title>Molecular pathology of age-related macular degeneration</article-title><source>Prog Retin Eye Res</source><year>2009</year><volume>28</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2008.10.001</pub-id><pub-id pub-id-type="pmid">19026761</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Ji</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: Funagata study</article-title><source>Ophthalmology</source><year>2008</year><volume>115</volume><fpage>1376</fpage><lpage>1381</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2007.11.015</pub-id><pub-id pub-id-type="pmid">18222000</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>JI</given-names></name></person-group><source>Age-related macular degeneration</source><year>2002</year><publisher-loc>New York</publisher-loc><publisher-name>Marcel Dekker</publisher-name></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonilha</surname><given-names>VL</given-names></name></person-group><article-title>Age and disease-related structural changes in the retinal pigment epithelium</article-title><source>Clin Ophthalmol</source><year>2008</year><volume>2</volume><fpage>413</fpage><lpage>424</lpage><pub-id pub-id-type="pmid">19668732</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruko</surname><given-names>I</given-names></name><name><surname>Iida</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>M</given-names></name><etal/></person-group><article-title>Clinical characteristics of exudative age-related macular degeneration in Japanese patients</article-title><source>Am J Ophthalmol</source><year>2007</year><volume>144</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2007.03.047</pub-id><pub-id pub-id-type="pmid">17509509</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomi</surname><given-names>F</given-names></name><name><surname>Tano</surname><given-names>Y</given-names></name></person-group><article-title>Popypoidal choroidal vasculopathy and treatments</article-title><source>Curr Opin Ophthalmol</source><year>2008</year><volume>19</volume><fpage>208</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1097/ICU.0b013e3282fb7c33</pub-id><pub-id pub-id-type="pmid">18408495</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cacket</surname><given-names>P</given-names></name><name><surname>Wong</surname><given-names>D</given-names></name><name><surname>Yeo</surname><given-names>I</given-names></name></person-group><article-title>A classification system for polypoidal choroidal vasculopathy</article-title><source>Retina</source><year>2009</year><volume>29</volume><fpage>187</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1097/IAE.0b013e318188c839</pub-id><pub-id pub-id-type="pmid">18827731</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byeon</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name><name><surname>Oh</surname><given-names>HS</given-names></name><etal/></person-group><article-title>Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients</article-title><source>Jpn J Ophthalmol</source><year>2008</year><volume>52</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1007/s10384-007-0498-2</pub-id><pub-id pub-id-type="pmid">18369702</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyers</surname><given-names>SM</given-names></name></person-group><article-title>A twin study on age-related macular degeneration</article-title><source>Trans Am Ophthalmol Soc</source><year>1994</year><volume>92</volume><fpage>775</fpage><lpage>843</lpage><pub-id pub-id-type="pmid">7886884</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname><given-names>CJ</given-names></name><name><surname>Webster</surname><given-names>AR</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><etal/></person-group><article-title>Genetic influence on early age-related maculopathy: a twin study</article-title><source>Ophthalmology</source><year>2002</year><volume>109</volume><fpage>730</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1016/S0161-6420(01)01049-1</pub-id><pub-id pub-id-type="pmid">11927430</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seddon</surname><given-names>JM</given-names></name><name><surname>Cote</surname><given-names>J</given-names></name><name><surname>Page</surname><given-names>WF</given-names></name><etal/></person-group><article-title>The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences</article-title><source>Arch Ophthalmol</source><year>2005</year><volume>123</volume><fpage>321</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1001/archopht.123.3.321</pub-id><pub-id pub-id-type="pmid">15767473</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heiba</surname><given-names>IM</given-names></name><name><surname>Elston</surname><given-names>RC</given-names></name><name><surname>Klein</surname><given-names>BE</given-names></name><etal/></person-group><article-title>Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study</article-title><source>Genet Epidemiol</source><year>1994</year><volume>11</volume><fpage>51</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1002/gepi.1370110106</pub-id><pub-id pub-id-type="pmid">8013888</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seddon</surname><given-names>JM</given-names></name><name><surname>Ajani</surname><given-names>UA</given-names></name><name><surname>Mitchell</surname><given-names>BD</given-names></name></person-group><article-title>Familial aggregation of age-related maculopathy</article-title><source>Am J Ophthalmol</source><year>1997</year><volume>123</volume><fpage>199</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">9186125</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klaver</surname><given-names>CC</given-names></name><name><surname>Wolfs</surname><given-names>RC</given-names></name><name><surname>Assink</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Genetic risk of age-related maculopathy. Population-based familial aggregation study</article-title><source>Arch Ophthalmol</source><year>1998</year><volume>116</volume><fpage>1646</fpage><lpage>1651</lpage><pub-id pub-id-type="pmid">9869796</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Yashar</surname><given-names>BM</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Age-related macular degeneration: a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease</article-title><source>Am J Hum Genet</source><year>2004</year><volume>41</volume><fpage>482</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1086/382786</pub-id><pub-id pub-id-type="pmid">14968411</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyengar</surname><given-names>SK</given-names></name><name><surname>Song</surname><given-names>D</given-names></name><name><surname>Klein</surname><given-names>BE</given-names></name><etal/></person-group><article-title>Dissection of genomewide-scan in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration</article-title><source>Am J Hum Genet</source><year>2004</year><volume>74</volume><fpage>20</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1086/380912</pub-id><pub-id pub-id-type="pmid">14691731</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majewski</surname><given-names>J</given-names></name><name><surname>Schultz</surname><given-names>DW</given-names></name><name><surname>Weleber</surname><given-names>RG</given-names></name><etal/></person-group><article-title>Age-related macular degeneration&#x02014;a genome scan in extended families</article-title><source>Am J Hum Gentet</source><year>2003</year><volume>73</volume><fpage>540</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1086/377701</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seddon</surname><given-names>JM</given-names></name><name><surname>Santangelo</surname><given-names>SL</given-names></name><name><surname>Book</surname><given-names>K</given-names></name><etal/></person-group><article-title>A Genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions</article-title><source>Am J Hum Genet</source><year>2003</year><volume>73</volume><fpage>780</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1086/378505</pub-id><pub-id pub-id-type="pmid">12945014</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>ML</given-names></name><name><surname>Schultz</surname><given-names>DW</given-names></name><name><surname>Edwards</surname><given-names>A</given-names></name><etal/></person-group><article-title>Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q</article-title><source>Arch Ophthalmol</source><year>1998</year><volume>116</volume><fpage>1082</fpage><lpage>1088</lpage><pub-id pub-id-type="pmid">9715689</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schick</surname><given-names>JH</given-names></name><name><surname>Iyengar</surname><given-names>SK</given-names></name><name><surname>Klein</surname><given-names>BE</given-names></name><etal/></person-group><article-title>A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study</article-title><source>Am J Hum Genet</source><year>2003</year><volume>72</volume><fpage>1412</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.1086/375500</pub-id><pub-id pub-id-type="pmid">12717633</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenealy</surname><given-names>SJ</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><etal/></person-group><article-title>Linkage analysis for age-related macular degeneration supports a gene on chromosome 10q26</article-title><source>Mol Vis</source><year>2004</year><volume>10</volume><fpage>57</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">14758336</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Scott</surname><given-names>WK</given-names></name><name><surname>Postel</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Ordered subset linkage analysis supports a susceptibility locus for age-related macular degeneration on chromosome 16p12</article-title><source>BMC Genet</source><year>2004</year><volume>5</volume><fpage>18</fpage><pub-id pub-id-type="doi">10.1186/1471-2156-5-18</pub-id><pub-id pub-id-type="pmid">15238159</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weeks</surname><given-names>DE</given-names></name><name><surname>Conely</surname><given-names>YP</given-names></name><name><surname>Tsai</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions</article-title><source>Am J Hum Genet</source><year>2004</year><volume>75</volume><fpage>174</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1086/422476</pub-id><pub-id pub-id-type="pmid">15168325</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barral</surname><given-names>S</given-names></name><name><surname>Francis</surname><given-names>PJ</given-names></name><name><surname>Schultz</surname><given-names>DW</given-names></name><etal/></person-group><article-title>Expanded genome scan in extended families with age-related macular degeneration</article-title><source>Invest Ophthalmol Vis Sci</source><year>2006</year><volume>47</volume><fpage>5453</fpage><lpage>5459</lpage><pub-id pub-id-type="doi">10.1167/iovs.06-0655</pub-id><pub-id pub-id-type="pmid">17122136</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>SA</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Yashar</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Meta-analysis of genome scans of age-related macular degeneration</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>2257</fpage><lpage>2264</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddi230</pub-id><pub-id pub-id-type="pmid">15987700</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>AO</given-names></name><name><surname>Fridley</surname><given-names>BL</given-names></name><name><surname>James</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Evaluation of clustering and genotype distribution for replication in genome wide association studies: the age-related eye disease study</article-title><source>PLoS ONE</source><year>2008</year><volume>3</volume><fpage>e3813</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0003813</pub-id><pub-id pub-id-type="pmid">19043567</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Morrison</surname><given-names>MA</given-names></name><name><surname>DeWan</surname><given-names>A</given-names></name><etal/></person-group><article-title>The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration</article-title><source>BMC Med Genet</source><year>2008</year><volume>9</volume><fpage>51</fpage><pub-id pub-id-type="doi">10.1186/1471-2350-9-51</pub-id><pub-id pub-id-type="pmid">18541031</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>RJ</given-names></name><name><surname>Zeiss</surname><given-names>C</given-names></name><name><surname>Chew</surname><given-names>EY</given-names></name><etal/></person-group><article-title>Complement factor H polymorphism in age-related macular degeneration</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>385</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1126/science.1109557</pub-id><pub-id pub-id-type="pmid">15761122</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>A</given-names></name><name><surname>Fisher</surname><given-names>SA</given-names></name><name><surname>Fritsche</surname><given-names>LG</given-names></name><etal/></person-group><article-title>Hypothetical ARMS2 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk</article-title><source>Hum Mol Genet</source><year>2005</year><volume>14</volume><fpage>3227</fpage><lpage>3236</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddi353</pub-id><pub-id pub-id-type="pmid">16174643</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakobsdottir</surname><given-names>J</given-names></name><name><surname>Conley</surname><given-names>YP</given-names></name><name><surname>Weeks</surname><given-names>DE</given-names></name><etal/></person-group><article-title>Susceptibility genes for age-related maculopathy on chromosome 10q26</article-title><source>Am J Hum Genet</source><year>2005</year><volume>77</volume><fpage>389</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1086/444437</pub-id><pub-id pub-id-type="pmid">16080115</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewan</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Hartman</surname><given-names>S</given-names></name><etal/></person-group><article-title>HTRA1 promoter polymorphism in wet age-related macular degeneration</article-title><source>Science</source><year>2006</year><volume>314</volume><fpage>989</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1126/science.1133807</pub-id><pub-id pub-id-type="pmid">17053108</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Camp</surname><given-names>NJ</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><etal/></person-group><article-title>A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration</article-title><source>Science</source><year>2006</year><volume>314</volume><fpage>992</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1126/science.1133811</pub-id><pub-id pub-id-type="pmid">17053109</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Wan</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><etal/></person-group><article-title>HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration</article-title><source>Mol Vis</source><year>2007</year><volume>13</volume><fpage>545</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">17438519</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>DJ</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><etal/></person-group><article-title>HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration</article-title><source>Cell Cycle</source><year>2007</year><volume>6</volume><fpage>1122</fpage><lpage>1125</lpage><pub-id pub-id-type="pmid">17426452</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Honda</surname><given-names>S</given-names></name><name><surname>Ishibashi</surname><given-names>K</given-names></name><etal/></person-group><article-title>ARMS2/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population</article-title><source>Am J Ophthalmol</source><year>2007</year><volume>144</volume><fpage>608</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2007.06.003</pub-id><pub-id pub-id-type="pmid">17692272</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuse</surname><given-names>N</given-names></name><name><surname>Miyazawa</surname><given-names>A</given-names></name><name><surname>Mengkegale</surname><given-names>M</given-names></name><etal/></person-group><article-title>Polymorphisms in Complement Factor H and Heminectin-1 genes in a Japanese Population with dry-type age-related macular degeneration</article-title><source>Am J Ophthalmol</source><year>2006</year><volume>142</volume><fpage>1074</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2006.07.030</pub-id><pub-id pub-id-type="pmid">17157600</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>H</given-names></name><name><surname>Umeda</surname><given-names>S</given-names></name><name><surname>Obazawa</surname><given-names>M</given-names></name><etal/></person-group><article-title>Complement factor H polymorphisms in Japanese population with age-related macular degeneration</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>156</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">16541016</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotoh</surname><given-names>N</given-names></name><name><surname>Yamada</surname><given-names>R</given-names></name><name><surname>Hiratani</surname><given-names>H</given-names></name><etal/></person-group><article-title>No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese</article-title><source>Hum Genet</source><year>2006</year><volume>120</volume><fpage>139</fpage><lpage>143</lpage><pub-id pub-id-type="doi">10.1007/s00439-006-0187-0</pub-id><pub-id pub-id-type="pmid">16710702</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Gehlbach</surname><given-names>PL</given-names></name><name><surname>Kabasawa</surname><given-names>I</given-names></name><etal/></person-group><article-title>Coding and noncoding variants in the CFH gene and cigarette smoking influence the risk of age-related macular degeneration in a Japanese population</article-title><source>Invest Ophthalmol Vis Sci</source><year>2007</year><volume>48</volume><fpage>5315</fpage><lpage>5319</lpage><pub-id pub-id-type="doi">10.1167/iovs.07-0426</pub-id><pub-id pub-id-type="pmid">17962488</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uka</surname><given-names>J</given-names></name><name><surname>Tamura</surname><given-names>H</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><etal/></person-group><article-title>No association of complement factor H gene polymorphism and age-related macular degeneration in the Japanese population</article-title><source>Retina</source><year>2006</year><volume>26</volume><fpage>985</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1097/01.iae.0000244068.18520.3e</pub-id><pub-id pub-id-type="pmid">17151483</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grassi</surname><given-names>MA</given-names></name><name><surname>Fingert</surname><given-names>JH</given-names></name><name><surname>Scheetz</surname><given-names>TE</given-names></name><etal/></person-group><article-title>Ethnic variation in AMD-associated complement factor H polymorphism p. Tyr402His</article-title><source>Hum Mutat</source><year>2006</year><volume>27</volume><fpage>921</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1002/humu.20359</pub-id><pub-id pub-id-type="pmid">16865697</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>LJ</given-names></name><name><surname>Liu</surname><given-names>DT</given-names></name><name><surname>Tam</surname><given-names>PO</given-names></name><etal/></person-group><article-title>Association of complement factor H polymorphism with exudative age-related macular degeneration</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>1536</fpage><lpage>1542</lpage><pub-id pub-id-type="pmid">17167412</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Vitbana</surname><given-names>EN</given-names></name><name><surname>Matbur</surname><given-names>R</given-names></name><etal/></person-group><article-title>Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>2613</fpage><lpage>2619</lpage><pub-id pub-id-type="doi">10.1167/iovs.07-0860</pub-id><pub-id pub-id-type="pmid">18515590</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Honda</surname><given-names>S</given-names></name><name><surname>Kuno</surname><given-names>S</given-names></name><etal/></person-group><article-title>Coding variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopahy</article-title><source>Ophthalmology</source><year>2009</year><volume>116</volume><fpage>304</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2008.11.011</pub-id><pub-id pub-id-type="pmid">19187823</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>B</given-names></name><name><surname>Merriam</surname><given-names>JE</given-names></name><name><surname>Zernant</surname><given-names>J</given-names></name><etal/></person-group><article-title>Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration</article-title><source>Nature Genet</source><year>2006</year><volume>38</volume><fpage>458</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1038/ng1750</pub-id><pub-id pub-id-type="pmid">16518403</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>AJ</given-names></name><name><surname>Islam</surname><given-names>FMA</given-names></name><name><surname>Guymer</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Analysis of rare variants in the complement component 2 (C2) and factor B (BF) genes refine association for age-related macular degeneration</article-title><source>Invest Ophthalmol Vis Sci</source><year>2009</year><volume>50</volume><fpage>540</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1167/iovs.08-2423</pub-id><pub-id pub-id-type="pmid">18806293</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maller</surname><given-names>JB</given-names></name><name><surname>Fagerness</surname><given-names>JA</given-names></name><name><surname>Reynolds</surname><given-names>RC</given-names></name><etal/></person-group><article-title>Variation in complement factor 3 is associated with risk of age-related macular degeneration</article-title><source>Nature Genet</source><year>2007</year><volume>39</volume><fpage>1200</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1038/ng2131</pub-id><pub-id pub-id-type="pmid">17767156</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yates</surname><given-names>JRW</given-names></name><name><surname>Sepp</surname><given-names>T</given-names></name><name><surname>Matharu</surname><given-names>BK</given-names></name><etal/></person-group><article-title>Complement C3 variant and the risk of age-related macular degeneration</article-title><source>N Eng J Med</source><year>2009</year><volume>357</volume><fpage>553</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa072618</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagerness</surname><given-names>JA</given-names></name><name><surname>Maller</surname><given-names>JB</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Variation near complement factor I is associated with risk of advanced AMD</article-title><source>Eur J Hum Genet</source><year>2009</year><volume>17</volume><fpage>100</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2008.140</pub-id><pub-id pub-id-type="pmid">18685559</pub-id></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Honda</surname><given-names>S</given-names></name><name><surname>Kuno</surname><given-names>S</given-names></name><etal/></person-group><article-title>Role of RDBP and SKIV2L variants in the major histocompatibility complex class III region in polypoidal choroidal vasculopathy etiology</article-title><source>Ophthalmology</source><year>2009</year><volume>116</volume><fpage>1502</fpage><lpage>1509</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2009.03.004</pub-id><pub-id pub-id-type="pmid">19556007</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seddon</surname><given-names>JM</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Adelman</surname><given-names>RA</given-names></name></person-group><article-title>Evaluation of the clinical age-related maculopathy staging system</article-title><source>Ophthalmol</source><year>2006</year><volume>113</volume><fpage>260</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2005.11.001</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="book"><source>R: A language and environment for statistical computing</source><year>2009</year><publisher-loc>Vienna</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname><given-names>Y</given-names></name><name><surname>Hochberg</surname><given-names>Y</given-names></name></person-group><article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title><source>J R Stat Soc</source><year>1995</year><volume>B57</volume><fpage>289</fpage><lpage>300</lpage></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agresti</surname><given-names>A</given-names></name></person-group><source>Categorical Data Analysis</source><year>2002</year><publisher-loc>New Jersey</publisher-loc><publisher-name>John Wiley &#x00026; Sons</publisher-name></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Guan</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Association of CFH, ARMS2, and HTRA1 polymorphisms with exudative age-related macular degeneration in a northern Chinese population</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1373</fpage><lpage>1381</lpage><pub-id pub-id-type="pmid">18682812</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>TK</given-names></name><name><surname>Chen</surname><given-names>LJ</given-names></name><name><surname>Liu</surname><given-names>DT</given-names></name><etal/></person-group><article-title>Multiple gene polymorphisms in the complement factor h gene are associated with exudative age-related macular degeneration in Chinese</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>3312</fpage><lpage>3317</lpage><pub-id pub-id-type="doi">10.1167/iovs.07-1517</pub-id><pub-id pub-id-type="pmid">18421087</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>NR</given-names></name><name><surname>Kang</surname><given-names>JH</given-names></name><name><surname>Kwon</surname><given-names>OW</given-names></name><etal/></person-group><article-title>Association between complement factor H gene polymorphism and neovascular age-related macular degeneration in Koreans</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>2071</fpage><lpage>2076</lpage><pub-id pub-id-type="doi">10.1167/iovs.07-1195</pub-id><pub-id pub-id-type="pmid">18223247</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>LI</given-names></name><name><surname>Chen</surname><given-names>SJ</given-names></name><name><surname>Cheng</surname><given-names>CY</given-names></name><etal/></person-group><article-title>Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients</article-title><source>Invest Ophthalmol Vis Sci</source><year>2006</year><volume>47</volume><fpage>3242</fpage><lpage>3246</lpage><pub-id pub-id-type="doi">10.1167/iovs.05-1532</pub-id><pub-id pub-id-type="pmid">16877387</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>CC</given-names></name><name><surname>Lu</surname><given-names>N</given-names></name><etal/></person-group><article-title>Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population</article-title><source>Chin Med J</source><year>2008</year><volume>121</volume><fpage>2525</fpage><lpage>2533</lpage><pub-id pub-id-type="pmid">19187590</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tam</surname><given-names>PO</given-names></name><name><surname>Ng</surname><given-names>TK</given-names></name><name><surname>Liu</surname><given-names>DT</given-names></name><etal/></person-group><article-title>HTRA1 variants in exudative age-related macular degeneration and interactions with smoking and CFH</article-title><source>Invest Ophthalmol Vis Sci</source><year>2008</year><volume>49</volume><fpage>2357</fpage><lpage>2365</lpage><pub-id pub-id-type="doi">10.1167/iovs.07-1520</pub-id><pub-id pub-id-type="pmid">18316707</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scmidt</surname><given-names>CQ</given-names></name><name><surname>Herbert</surname><given-names>AP</given-names></name><name><surname>Hocking</surname><given-names>HG</given-names></name><etal/></person-group><article-title>Translational mini-review series on complement factor H: structural and functional correlations for factor H</article-title><source>Cln Exp Immun</source><year>2008</year><volume>151</volume><fpage>14</fpage><lpage>24</lpage></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssen</surname><given-names>BJC</given-names></name><name><surname>Christodoulidou</surname><given-names>A</given-names></name><name><surname>McCarthy</surname><given-names>A</given-names></name><etal/></person-group><article-title>Structures of C3b reveals conformational changes that underlie complement activity</article-title><source>Nature</source><year>2006</year><volume>444</volume><fpage>213</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1038/nature05172</pub-id><pub-id pub-id-type="pmid">17051160</pub-id></mixed-citation></ref></ref-list><fn-group><fn><p>The first two authors Goto and Akahori have contributed equally to this work.</p></fn></fn-group></back></article>